Life Sciences Market Activities, Higher for Longer, and Our Latest Innovation Wave Podcasts

Life Sciences Market Activities, Higher for Longer, and Our Latest Innovation Wave Podcasts

David H. Crean highlights robust activity in life sciences for Q1 2024, featuring key M&As, IPOs, and venture funding, despite economic challenges, as detailed by DealForma data. Read the full report

 

DealForma Research

Explore More
Autoimmune R&D Partnerships, M&A, Ventures, and IPOs by TA - Q2 to QTD Q4 2024 Review

Autoimmune R&D Partnerships, M&A, Ventures, and IPOs by TA – Q2 to QTD Q4 2024 Review

MedTech, Device, Digital Health, Wearables – M&A, Ventures and IPOs in Q3 2024

MedTech, Device, Digital Health, Wearables – M&A, Ventures and IPOs in Q3 2024

Biopharma Therapeutics and Platforms IPO Activity - Q3 2024

Biopharma Therapeutics and Platforms IPO Activity – Q3 2024

All of this by stage, disease indication, modality, target…

Schedule your Demo
+ 0 k
Licensing Deals
+ 0 k
M&A
+ 0 k
Other Deals
+ 0 k
Funding Rounds
+ 0 k
Company Profiles
+ 0 k
Drug Sales Figures
DealForma Logo

DealForma is the biopharma deal database providing you comprehensive information and dedicated analyst support to help you be more confident using quality data in your business development research.

Linkedin

Database

Company

Comparisons

Website Design by Once Interactive